about
Production of α-galactosylceramide by a prominent member of the human gut microbiotaSelf-Organisation, Thermotropic and Lyotropic Properties of Glycolipids Related to their Biological Implications.Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells.Human glycolipid transfer protein (GLTP) genes: organization, transcriptional status and evolution.The 3-Deoxy Analogue of α-GalCer: Disclosing the Role of the 4-Hydroxyl Group for CD1d-Mediated NKT Cell Activation.Stimulation of natural killer T cells by glycolipidsHeteroaromatic Moieties in the Sphingosine Backbone of α-Galactosylceramides for Noncovalent Interactions with CD1dDesign and Evaluation of ω-Hydroxy Fatty Acids Containing α-GalCer Analogues for CD1d-Mediated NKT Cell Activation.Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cellsThe stimulating adventure of KRN 7000.Asymmetric synthesis of D-ribo-phytosphingosine from 1-tetradecyne and (4-methoxyphenoxy)acetaldehyde.Synthesis of immunostimulatory alpha-C-galactosylceramide glycolipids via Sonogashira coupling, asymmetric epoxidation, and trichloroacetimidate-mediated epoxide opening.One-pot syntheses of immunostimulatory glycolipidsImmunotherapy for lung cancers.ABO blood group and related antigens, natural antibodies and transplantation.Impact of sugar stereochemistry on natural killer T cell stimulation by bacterial glycolipids.Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.The total synthesis of immunostimulant α-galactosylceramides from naturally configured α-galactoside raffinose.Glycolipids as immunostimulating agents.Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides.Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.Identification of iGb3 and iGb4 in melanoma B16F10-Nex2 cells and the iNKT cell-mediated antitumor effect of dendritic cells primed with iGb3Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?Integrating ReSET with glycosyl iodide glycosylation in step-economy syntheses of tumor-associated carbohydrate antigens and immunogenic glycolipidsTailored design of NKT-stimulatory glycolipids for polarization of immune responses.The U24 protein from human herpesvirus 6 and 7 affects endocytic recyclingSilencing the porcine iGb3s gene does not affect Galα3Gal levels or measures of anticipated pig-to-human and pig-to-primate acute rejection.Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells.Synthesis of a 2"-deoxy-β-GalCerSyntheses and biological activities of KRN7000 analogues having aromatic residues in the acyl and backbone chains with varying stereochemistry.CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs.C-Galactosylceramide Diastereomers via Sharpless Asymmetric Epoxidation ChemistrySynthesis of a versatile building block for the preparation of 6-N-derivatized α-galactosyl ceramides: rapid access to biologically active glycolipids.Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand.Synthesis and evaluation of amino-modified alpha-GalCer analogues.Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis.
P2860
Q28534671-0938EC13-9557-44D6-BD64-C65EE2509FE7Q30316037-0ED0AA3B-7ED7-4A50-AE39-F76F8E45D32CQ30432794-4A41238E-E4DA-412D-9484-790B2B60BA2BQ33318973-865C9EE5-229C-4D39-A6BE-E3217787ADA5Q33598825-12BAA084-EA8E-4699-BBCB-740A174F3A17Q33599059-1498C7BF-933D-481C-96B3-3AB2F029848FQ33630528-94BAC4DB-EA6E-45AE-88C0-33204CB8632AQ33636210-935C9A6E-3765-49DB-9D57-62DBCADC8B30Q33745321-8AD56D16-FB22-4E61-A10C-4231D912E06CQ33843406-C9332384-6351-486F-9B7F-BA868B9EB804Q33944068-95B6A6B2-FF2B-49CF-A4A6-D92C0FBD375AQ33959266-A2D602B9-9513-4E83-A198-3EB0FF3A10AFQ34031730-650E4475-B4FB-45C0-90F8-12F181F94465Q34557611-E395305F-816A-4FBB-ABF6-618CC3C63979Q34592358-054F3B76-E10A-4559-85DC-7ABED016365AQ35841349-E537CEE6-C2C6-45A9-8EA9-162C999C983EQ35850748-3A4B4E1C-74E1-474B-9298-8DF2D810F45AQ36099374-6A08BF1A-725B-4D3D-B07D-BE1365E60375Q36517889-8B63DFC1-1D46-4730-82AA-26B38F785AD7Q37218293-230B3E28-9DAA-488B-97BC-37A371CEDA24Q37439660-2B5A2DF8-CD5A-4099-90DE-F4D41DC884BEQ37483091-32E979CD-D541-4411-AF7F-A988DA451ADCQ37582663-85235AD3-85E3-45BD-A81F-4D9B914FA0CCQ37701761-A529D432-9059-4956-869D-32DDE3782A7AQ39196835-B64A18D3-CD95-4695-82FD-521B09678AECQ39773166-D7B5267D-9BBC-4DA2-9A58-5466F4F76A63Q39828679-362FF6E4-1A49-4E98-AA2B-0ACCD2CEF443Q39843991-B71BEB2D-ECC5-4FCB-BB3B-CEC57334D7CBQ39958212-4AE159DE-4547-4D4B-87B3-2B5B0C286389Q41617889-95A47820-F6D4-4F92-A585-60D8E872F4B5Q41903337-F8A68600-4FEB-40B6-AB39-17EBE23A6EEAQ41981374-32772A84-A0C8-4A6C-A67B-712BD384FC7AQ42160618-F828587E-D550-47B2-8031-A882A8E29B3BQ42182906-1B2ED376-4B15-4D94-B877-8ABB3DEB77D4Q42733983-BD1BB9D7-3FB1-45AC-B415-86104690208BQ42954809-206E72FE-5ED2-4E09-9D5D-8030241BEE52
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Glycolipids for natural killer T cells.
@ast
Glycolipids for natural killer T cells.
@en
type
label
Glycolipids for natural killer T cells.
@ast
Glycolipids for natural killer T cells.
@en
prefLabel
Glycolipids for natural killer T cells.
@ast
Glycolipids for natural killer T cells.
@en
P2093
P356
P1476
Glycolipids for natural killer T cells.
@en
P2093
Albert Bendelac
Luc Teyton
Paul B Savage
P2860
P304
P356
10.1039/B510638A
P577
2006-06-09T00:00:00Z